1. Home
  2. CNTB vs CPHC Comparison

CNTB vs CPHC Comparison

Compare CNTB & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • CPHC
  • Stock Information
  • Founded
  • CNTB 2012
  • CPHC 1994
  • Country
  • CNTB United States
  • CPHC United States
  • Employees
  • CNTB N/A
  • CPHC N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • CPHC Services-Misc. Amusement & Recreation
  • Sector
  • CNTB Health Care
  • CPHC Consumer Discretionary
  • Exchange
  • CNTB Nasdaq
  • CPHC Nasdaq
  • Market Cap
  • CNTB 114.8M
  • CPHC 92.5M
  • IPO Year
  • CNTB 2021
  • CPHC 1994
  • Fundamental
  • Price
  • CNTB $1.57
  • CPHC $16.43
  • Analyst Decision
  • CNTB Strong Buy
  • CPHC
  • Analyst Count
  • CNTB 2
  • CPHC 0
  • Target Price
  • CNTB $7.50
  • CPHC N/A
  • AVG Volume (30 Days)
  • CNTB 184.6K
  • CPHC 2.2K
  • Earning Date
  • CNTB 09-05-2025
  • CPHC 11-06-2025
  • Dividend Yield
  • CNTB N/A
  • CPHC 1.68%
  • EPS Growth
  • CNTB N/A
  • CPHC N/A
  • EPS
  • CNTB N/A
  • CPHC 0.03
  • Revenue
  • CNTB $1,965,000.00
  • CPHC $60,069,270.00
  • Revenue This Year
  • CNTB N/A
  • CPHC N/A
  • Revenue Next Year
  • CNTB N/A
  • CPHC N/A
  • P/E Ratio
  • CNTB N/A
  • CPHC $566.37
  • Revenue Growth
  • CNTB N/A
  • CPHC N/A
  • 52 Week Low
  • CNTB $1.56
  • CPHC $16.15
  • 52 Week High
  • CNTB $2.20
  • CPHC $22.93
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 39.75
  • CPHC 38.78
  • Support Level
  • CNTB $1.63
  • CPHC $16.40
  • Resistance Level
  • CNTB $1.79
  • CPHC $16.87
  • Average True Range (ATR)
  • CNTB 0.18
  • CPHC 0.27
  • MACD
  • CNTB -0.04
  • CPHC 0.05
  • Stochastic Oscillator
  • CNTB 0.39
  • CPHC 2.88

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About CPHC Canterbury Park Holding Corporation 'New'

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

Share on Social Networks: